TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: Breast Cancer Tape ready; control Program Plans for 1978 Subject Of July 15 Meeting June 17, 1977
TCL Archive Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee November 16, 1979